Medicina (Nov 2022)

Clinical Outcomes of Transplanted Kidneys from Deceased Donors Using Different Generic Preservation Solutions

  • Aureliusz Kolonko,
  • Natalia Słabiak-Błaż,
  • Robert Król,
  • Andrzej Więcek

DOI
https://doi.org/10.3390/medicina58111579
Journal volume & issue
Vol. 58, no. 11
p. 1579

Abstract

Read online

Background and Objectives: StoreProtect Plus® is a preserving solution for cold organ storage, with a composition identical to Institute Georges Lopez (IGL-1) solution. The aim of this single center study was to compare the clinical performance of StoreProtect Plus with the generic counterpart of University of Wisconsin preservation fluid, named SPS-1®. Materials and Methods: The clinical outcomes of 168 consecutive organs preserved with StoreProtect Plus solution and 167 organs preserved with SPS-1 solution were compared. During an 18-month post-transplant follow-up period, kidney graft function, the frequency of acute rejection, post-transplant diabetes, and infectious complications, as well as patient and graft survival were analyzed. Results: There was significantly more immediate graft function (IGF) (39.3 vs. 24.0%; p p partial = 0.217; p partial = 0.147; p 1.5 mg/dL prior to organ procurement (rpartial = −0.198; p partial = −0.170; p partial = −0.214; p Conclusions: The higher occurrence of IGF was found in kidney transplant recipients whose organs were preserved using StoreProtect Plus solution as compared with SPS-1 solution. The two groups did not differ in kidney graft function, the frequency of post-transplant complications, as well as patient and graft survival.

Keywords